ADHD Pharmacotherapy: An Update on Treatment Strategies and Clinical Considerations

CAN-eng

$0

free

Mainpro+

30 min

Mental Health

0.5 Credits

LEARN MORE

Course Description

ADHD is a complex neurodevelopmental disorder that requires individualized treatment to improve patient outcomes. This program aims to support clinicians in optimizing ADHD management by reviewing current guideline-based treatment recommendations, strategies for medication selection and switching, key differences between ADHD drug formulations, and practical considerations when treating individuals with ADHD.  

Course Features: 

– 2 Ask the Expert videos, 
– 1 downloadable resource.  

Content Covered: 

Module: An Update on Treatment Strategies and Clinical Considerations

• This program has received financial support from Sun Pharma Canada Inc. in the form of an unrestricted educational grant. 

Course Details

Expiry Date: 2027-06-24

Professions: Physician

Faculty

  • Christine Palmay, MD, CCFP, FCFP
  • Jeffrey Habert, MD, CCFP, FCFP
  • Atul Khullar, MD MSc FRCPC FAASM DABPN

Accreditation

This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to [insert # of credits] Mainpro+® Certified Activity credit(s).
CERT+ Session ID: 303874-001

Learning Objective(s)

Upon completion of this continuing education program, participants will be better able to:​

  • Recognize the signs and symptoms of ADHD to be able to accurately make a diagnosis. 
  • Apply guideline-based pharmacologic treatment for ADHD, including initiation and optimization of stimulant therapy.
  • Individualize treatment using non-stimulant options and stimulant formulation strategies.